AgeX Therapeutics lands $10 mln

AgeX Therapeutics Inc, a subsidiary of BioTime Inc, has raised $10 million in funding. The investors were not named; however, according to an announcement on the fundraising, BioTime has an 85 percent stake in AgeX after the closing. Based in Alameda, California, AgeX is a biotech company focused on aging and age-related diseases.

Source: Press Release

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!